• Home
  • About us
    • Mission
    • The Board’s Presentation
  • News
    • What’s New on CytoPrevent
    • Board’s Position Papers
  • Guidelines & Regulations
  • Resources
    • Studies
    • Videos
    • Useful Links
  • Events
    • Congresses
  • Contact
Hazardous Drug Safety: Clarifying the confusion about closed systems

Hazardous Drug Safety: Clarifying the confusion about closed systems

by CytoPrevent | Sep 26, 2022 | What’s new on CytoPrevent

Seth Eisenberg (Professional Practice Coordinator, Infusion Services, Seattle Cancer Care Alliance)     Hazardous Drugs Risks associated with exposure to hazardous drugs (HDs) such as chemotherapy, have been well doc-umented over the past two decades and...
ISOPP Standards for the Safe Handling of Cytotoxics

ISOPP Standards for the Safe Handling of Cytotoxics

by CytoPrevent | Aug 31, 2022 | What’s new on CytoPrevent

ISOPP Standards for the Safe Handling of Cytotoxics   Since the initial release of the International Society of Oncology Pharmacy Practitioners (ISOPP) Standards for the Safe Handling of Cytotoxic Drugs in 2007, much has evolved in oncology pharmacy. Safe...
Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym

Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym

by CytoPrevent | Jun 23, 2022 | Studies

Seth Eisenberg British Journal of Nursing (BJN), 2022, Vol 31, No 10 (Oncology Supplement)    ABSTRACT Exposure to cytotoxic chemotherapy can result in acute and chronic conditions including nausea, headaches, rashes, miscarriages, infertility and genetic...
EP calls for action: strengthening Europe in the fight against cancer

EP calls for action: strengthening Europe in the fight against cancer

by CytoPrevent | Jan 11, 2022 | What’s new on CytoPrevent

Press Release of the European Parliament   On 9 December 2021, Parliament’s Special Committee on Beating Cancer adopted its final proposals on how to strengthen the EU’s role in the fight against cancer. They include the following:   1. Taking stronger EU...
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work

Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work

by CytoPrevent | Dec 30, 2021 | What’s new on CytoPrevent

Press Release – 16 December 2021   The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances...
« Older Entries

Legal Mentions

Cookies Policy

Contact Us


Follow us on Twitter

ESMO

 

Loading Comments...